These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9510444)

  • 1. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
    Koyanagi H; Nakamura Y; Yanagawa H
    Acta Paediatr; 1998 Jan; 87(1):32-6. PubMed ID: 9510444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control study of giant coronary aneurysms due to Kawasaki disease.
    Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Yanagawa H
    Pediatr Int; 2003 Aug; 45(4):410-3. PubMed ID: 12911476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
    Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease.
    Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Sonobe T; Yanagawa H
    Pediatr Int; 2004 Feb; 46(1):33-8. PubMed ID: 15043662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant coronary aneurysms due to Kawasaki disease: a case-control study.
    Nakamura Y; Yashiro M; Oki I; Tanihara S; Ojima T; Yanagawa H
    Pediatr Int; 2002 Jun; 44(3):254-8. PubMed ID: 11982891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
    Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to cardiac sequelae of Kawasaki disease.
    Zhang T; Yanagawa H; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
    Eur J Pediatr; 1999 Sep; 158(9):694-7. PubMed ID: 10485297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
    Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C
    Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
    Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
    J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
    Liu MY; Liu HM; Wu CH; Chang CH; Huang GJ; Chen CA; Chiu SN; Lu CW; Lin MT; Chang LY; Wang JK; Wu MH
    BMC Pediatr; 2017 Jun; 17(1):139. PubMed ID: 28587647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease.
    Tsuda E; Hamaoka K; Suzuki H; Sakazaki H; Murakami Y; Nakagawa M; Takasugi H; Yoshibayashi M
    Am Heart J; 2014 Feb; 167(2):249-58. PubMed ID: 24439987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
    Yamashita M; Ae R; Yashiro M; Aoyama Y; Sano T; Makino N; Nakamura Y
    Pediatr Cardiol; 2017 Feb; 38(2):375-380. PubMed ID: 27878631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alanine aminotransferase concentrations in patients with Kawasaki disease.
    Uehara R; Yashiro M; Hayasaka S; Oki I; Nakamura Y; Muta H; Ishii M; Matsuishi T; Sonobe T; Yanagawa H
    Pediatr Infect Dis J; 2003 Sep; 22(9):839-42. PubMed ID: 14515833
    [No Abstract]   [Full Text] [Related]  

  • 16. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children.
    Garrido-García LM; Morán-Villaseñor E; Yamazaki-Nakashimada MA; Cravioto P; Galván F
    Cardiol Young; 2018 Mar; 28(3):386-390. PubMed ID: 28847341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and psychosocial health in children who have had Kawasaki disease.
    Baker AL; Gauvreau K; Newburger JW; Sundel RP; Fulton DR; Jenkins KJ
    Pediatrics; 2003 Mar; 111(3):579-83. PubMed ID: 12612239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide survey of coronary aneurysms with diameter >6 mm in Kawasaki disease in Korea.
    Jang GY; Kang IS; Choi JY; Bae EJ; Kim YH; Kim SH; Ma JS
    Pediatr Int; 2015 Jun; 57(3):367-72. PubMed ID: 25406095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant coronary artery aneurysms in Kawasaki disease: the cost of a missed diagnosis.
    Marta L; Francisco A; Anjos R
    Cardiol Young; 2013 Aug; 23(4):608-9. PubMed ID: 23910022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six principal symptoms and coronary artery sequelae in Kawasaki disease.
    Nakamura Y; Yashiro M; Sadakane A; Aoyama Y; Oki I; Uehara R; Yanagawa H
    Pediatr Int; 2009 Oct; 51(5):705-8. PubMed ID: 19419505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.